• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 457043 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418995864 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418995864 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock to Watch: Pacific Biosciences of California Up 7.2% (PACB)

Published on Mon, 03/11/2013 - 12:24
By Adrienne Chilton

Pacific Biosciences of California (NASDAQ:PACB) is one of today's best performing low-priced stocks, up 7.2% to $2.54 on 1.7x average daily volume. Pacific Biosciences of California has traded 718,000 shares thus far today, vs. average volume of 427,000 shares per day. The stock has outperformed the Dow (7.2% to the Dow's 0.3%) and outperformed the S&P 500 (7.2% to the S&P's 0.2%) during today's trading.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

Over the past year, Pacific Biosciences of California has traded in a range of $1.06 to $3.99 and is now at $2.54, 140% above that low. The 200-day and 50-day moving averages have moved 0.05% higher and 2.97% higher over the past week, respectively.

Pacific Biosciences of California (NASDAQ:PACB) has potential upside of 1.7% based on a current price of $2.54 and analysts' consensus price target of $2.58. The stock should find initial support at its 50-day moving average (MA) of $2.31 and further support at its 200-day MA of $1.93.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Ventas had the Lowest Relative Performan...

Here are 5 stocks in the Specialized REITs industry ranked by performance. We compiled ...

Bottom 5 Companies in the Specialized Fi...

Here are 5 stocks in the Specialized Finance industry ranked by performance. We compil ...

Short-term Underperformance Detected in ...

Below are five companies in the Semiconductors industry that underperformed yesterday o ...

Shares of FormFactor Underperformed its ...

Here are 5 stocks in the Semiconductor Equipment industry ranked by performance. We co ...

Bottom 5 Companies in the Retail REITs I...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...

Bottom 5 Companies in the Restaurants In...

Below are five companies in the Restaurants industry that underperformed yesterday on a ...

Analysis of Relative Performance in the ...

Below are five companies in the Residential REITs industry that underperformed yesterda ...

Short-term Underperformance Detected in ...

Analysis was conducted on the Reinsurance industry to measure relative performance to f ...